Zoetis ZTS
NYSE ZTS
$73.31 -0.25 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Zoetis (ZTS) Other Non-Current Liabilities (2012 - 2026)

Zoetis' (ZTS) quarterly Other Non-Current Liabilities came in at $288.0 million in Q2 2026, up 5.11% year-over-year from $274.0 million in Q2 2025, and up 2.49% quarter-over-quarter from $281.0 million in Q1 2026.

Analysis

Zoetis (ZTS) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Other Non-Current Liabilities for 15 consecutive years, with $288.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 5.11% year-over-year to $288.0 million in Q2 2026; TTM through Jun 2026 was $288.0 million, a 5.11% increase from a year earlier, with the FY2025 full-year figure at $276.0 million, up 1.47% from the prior year.
  • Other Non-Current Liabilities was $288.0 million for Q2 2026 at Zoetis, up from $281.0 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $288.0 million in Q2 2026 and troughed at $241.0 million in Q3 2022.
  • A 5-year average of $268.4 million and a median of $271.5 million in 2023 frame the typical range for Other Non-Current Liabilities.
  • Across the five-year window, Other Non-Current Liabilities fell 6.95% in 2022 and rose 11.2% in 2023, its largest moves.
  • Over 5 years, Other Non-Current Liabilities stood at $258.0 million in 2022, then advanced by 5.04% to $271.0 million in 2023, then increased by 0.37% to $272.0 million in 2024, then climbed by 1.47% to $276.0 million in 2025, then gained by 4.35% to $288.0 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $288.0 million (Q2 2026), $281.0 million (Q1 2026), and $276.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 288.00 Mn
Mar 31, 2026 281.00 Mn
Dec 31, 2025 276.00 Mn
Sep 30, 2025 270.00 Mn
Jun 30, 2025 274.00 Mn
Mar 31, 2025 277.00 Mn
Dec 31, 2024 272.00 Mn
Sep 30, 2024 274.00 Mn
Jun 30, 2024 267.00 Mn
Mar 31, 2024 277.00 Mn
Dec 31, 2023 271.00 Mn
Sep 30, 2023 262.00 Mn
Jun 30, 2023 278.00 Mn
Mar 31, 2023 262.00 Mn
Dec 31, 2022 258.00 Mn
Sep 30, 2022 241.00 Mn
Jun 30, 2022 250.00 Mn
Mar 31, 2022 254.00 Mn
Dec 31, 2021 257.00 Mn
Sep 30, 2021 259.00 Mn